Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility

BACKGROUND: Although therapeutic hypothermia improves the outcome of neonatal hypoxic-ischemic encephalopathy (HIE), its efficacy is still limited. This preliminary study evaluates the safety and feasibility of the combination therapy with erythropoietin (Epo), magnesium sulfate and hypothermia in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Nonomura, Miho, Harada, Sayaka, Asada, Yuki, Matsumura, Hisako, Iwami, Hiroko, Tanaka, Yuko, Ichiba, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325796/
https://www.ncbi.nlm.nih.gov/pubmed/30621649
http://dx.doi.org/10.1186/s12887-018-1389-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325796/
https://www.ncbi.nlm.nih.gov/pubmed/30621649
http://dx.doi.org/10.1186/s12887-018-1389-z

Ejemplares similares